56 results on '"Franchin G"'
Search Results
2. PO-1422 Hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer
3. OC-0460 Deep learning based time to event analysis with PET, CT and joint PET/CT for H&N cancer prognosis
4. PO-1107 miR-9 as predictor of response to Radiotherapy and Cetuximab in patients with head and neck cancers
5. PO-0965 Vitamin D, vitamin B12 and acute toxicity in head and neck cancer patients undergoing radiotherapy.
6. OC-0623 SMAD3 expression and genetic variation could predict response to chemoradiation in rectal cancer
7. OC-0526 Deep learning based time-to-event prediction for a large multicentric cohort of H&N cancer patients
8. Additively manufactured geopolymer structured heterogeneous catalysts for biodiesel production
9. PD-0662: Can PNI and BMI predict severe radiation induced toxicities in Head and Neck cancer?
10. PO-0802: Impact of LINE-1 methylation on survival in patients with locally advanced oropharyngeal carcinoma.
11. PO-0951: Which is the best once-daily schedule for partial breast irradiation?Results of three phase-2 trials
12. Nanocrystalline titanium carbide/carbon composites as irradiation targets for isotopes production
13. M360 ATYPICAL SJÖGREN'S SYNDROME INITIALLY PRESENTING AS LYMPHOCYTIC INTERSTITIAL PNEUMONITIS FOLLOWED BY IMMUNE THROMBOCYTOPENIA
14. Predictive Value of Dosimetric Measures on Lung Toxicity in Randomized Trial of Radical RT with Intact Lung in Malignant Pleural Mesothelioma
15. The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant
16. Dosimetric Analysis, Acute Toxicity and Long-Term Outcome of Craniospinal Irradiation Using Helical Tomotherapy in Children and Adults
17. EP-1906 CBCT delta-radiomics for predicting complete pathological response of rectal cancer after CT-RT
18. EP-1904 3T CE-MRI (peri)tumoral radiomics for prediction of lymphovascular invasion in early breast cancer
19. EP-1143 Regional nodal failure after primary treatment for differentiated thyroid cancer.
20. EP-1139 Prognostic impact of hematological profile in oropharyngeal cancer treated with chemoradiotherapy
21. OC-0500 Radical Hemi-thoracic Radiotherapy vs. Palliative Radiotherapy for Malignant Pleural Mesothelioma.
22. EP-1614 Incidence of second malignancies among pediatric patients treated with helical Tomotherapy
23. EP-1905 CT /PET based dosiomics and radiomics model predicts local control of nasopharyngeal carcinoma
24. PO-182 Prognostic impact of hematological profile in oropharyngeal cancer treated with chemoradiotherapy
25. PO-164 Regional nodal failure after primary treatment for differentiated thyroid cancer
26. PO-063 Induction chemotherapy followed by radiotherapy for organ preservation in Oropharyngeal Cancer
27. PO-065 Do comorbidities affect survival in head and neck cancer treated with Cetuximab and Radiotherapy?
28. PO-122 CT /PET based dosiomics and radiomics model predicts local control of nasopharyngeal carcinoma
29. 303. Radiomic feature changes on cone-beam CT during RT for rectal cancer
30. Prognostic Significance of Immune Microenvironmental Factors in Undifferentiated Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy
31. IMPROVEMENT OF SYSTEMIC SCLEROSIS-LIKE SYMPTOMS AFTER THERAPY FOR MULTIPLE MYELOMA
32. PO-0777: Intensified IMRT with concurrent chemotherapy for locally advanced esophageal carcinoma
33. EP-1246: Radiotherapy after autologous stem cell transplant in recurrent or refractory hodgkin's lymphoma
34. EP-1593: Accuracy of TCP model for nasopharyngeal cancer after more than five years average follow-up
35. PO-0675: Radical radiotherapy in ologometastatic breast cancer patients
36. EP-1088: Is time from symptom to treatment a prognostic factor in stage III-IV head and neck cancer patients?
37. PO-0666: Comparing the efficacy of low-dose radiotherapy in patients with aggressive and indolent lymphomas
38. Radical Radiation Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors
39. Multiplexed Plasma Cytokine Chemokine and Growth Factor Profiling in Early-Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiation Therapy
40. Extended Pleurectomy/Decortication or Surgical Biopsy in the Era of High Doses of Radiation Therapy for Malignant Pleural Mesothelioma
41. SBRT for Re-irradiation of Persistent or Recurrent Locally Advanced NSCLC
42. Plasmatic Cytokine Levels in Lung Cancer Patients Undergoing Definitive Radiation Therapy
43. Radical Pleurectomy/Decortication Followed by High Dose of Radiation Therapy Delivered With Tomotherapy for Malignant Pleural Mesothelioma: Final Results With Long-term Follow-up
44. Clinical pharmacist to improve the pharmacological appropriateness in residential social care for elderly
45. High-dose Radiation Therapy Delivered With Tomotherapy to the Intact Lung for Malignant Pleural Mesothelioma
46. 1085 Generation of EBV-specific CTL Lines Enriched in BARF1 Specificities for Improved Adoptive Immunotherapy of Nasopharyngeal Carcinoma
47. Tomotherapy After Pleurectomy/decortication For Malignant Pleural Mesothelioma Allows The Delivery Of Full Dose Of Radiation In Patients With Intact Lung
48. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma
49. Nasopharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy
50. Daily low-dose paclitaxel and concurrent thoracic radiation in locally advanced NSCLC: Preliminary results of a radiobiology-based schedule in a phase I study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.